連續性腎臟替代療法 (CRRT) 市場規模、佔有率和成長分析：按產品、按模式、按年齡層、按最終用戶、按地區 - 行業預測，2024-2031 年

2022年全球連續性腎臟替代療法（CRRT）市場規模估值為13億美元，從2023年的14億美元增加至2031年的26.1億美元，在預測期內（2024-2031年）預計將以複合年增率成長8.1%。

連續性腎臟替代治療（CRRT）市場主要受到COVID-19患者急性腎損傷（AKI）病例激增的推動，據報道CRRT的需求將達到先前人群的五倍，預計將出現顯著成長。製造商和政府積極努力提高人們對 CRRT 和慢性腎臟病(CKD) 的認知，進一步推動了疫情期間使用量的增加。疫情也為當地製造商創造了有利的環境，導致對先進 CRRT 設備的需求增加。此外，兒科 CRRT 產品的進步預計將進​​一步推動市場擴張。美國在 CRRT 市場保持主導地位，受益於 AKI 的高盛行率以及擁有大量醫院的強大醫療基礎設施。除此之外，AKI 相關住院人數的增加和末期腎病患病率的增加是該地區市場成長的堅實基礎。鑑於這些趨勢，預計美國CRRT 市場在預測期內將保持穩定的複合年成長率，為醫療保健行業的相關人員帶來光明的前景。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 專利分析
• 貿易分析
• 技術分析
• 價值鏈分析
• 客戶和購買標準分析

連續性腎臟替代療法 (CRRT) 市場：依產品

• 市場概況
• 透析液和置換液
• 消耗品
  • 血液過濾器
  • 譜系套裝管
  • 其他
• CRRT系統

連續性腎臟替代療法 (CRRT) 市場：按方式分類

• 市場概況
• 連續性靜脈血液濾過
• 連續性靜脈血液濾過透析
• 連續性靜脈血液血液透析機
• 緩慢連續超過濾

連續性腎臟替代療法 (CRRT) 市場：依年齡層別

• 市場概況
• 成人
• 兒科/新生兒

連續性腎臟替代療法 (CRRT) 市場：按最終用戶分類

• 市場概況
• 醫院
• 門診治療
• 居家醫療
• 其他

按地區分類的連續性腎臟替代療法 (CRRT) 市場規模

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Baxter International, Inc.（US）
• Fresenius Medical Care AG & Co. KGaA（Germany）
• Nikkiso Co., Ltd.（Japan）
• B. Braun Melsungen AG（Germany）
• Medtronic PLC（Ireland）
• Asahi Kasei Corporation（Japan）
• Toray Medical Co., Ltd.（Japan）
• Nipro Corporation（Japan）
• Infomed SA（Switzerland）
• Medica SPA（Italy）
• Medites Pharma Spol. SRO（Czech Republic）
• Medical Components, Inc.（US）
• SWS Hemodialysis Care Co., Ltd.（China）
• Ningbo Tianyi Medical Devices Co., Ltd.（China）
• Anjue Medical Equipment Co., Ltd.（China）
• Kimal（UK）
• Jiangxi Sanxin Medtech Co., Ltd.（China）
• Allmed Medical Products Co., Ltd.（China）
• Dialco Medical Inc.（US）
• Browndove Healthcare Pvt. Ltd.（India）
• Steris PLC（US）
• Kuraray Medical PLC（Japan）
• Livanova PLC（UK）
• Diaverum Deutschland GmbH（Germany）
• Sembcorp Industries（Singapore）

Global Continuous Renal Replacement Therapy Market size was valued at USD 1.30 billion in 2022 and is poised to grow from USD 1.40 billion in 2023 to USD 2.61 billion by 2031, growing at a CAGR of 8.1% in the forecast period (2024-2031).

The Continuous Renal Replacement Therapy (CRRT) market is poised for substantial growth, driven primarily by the surge in Acute Kidney Injury (AKI) cases among COVID-19 patients, with demand for CRRT reported to be five times higher than in previous populations. This increase in utilization during the pandemic has been further bolstered by proactive initiatives from both manufacturers and governments to raise awareness about CRRT and chronic kidney disease (CKD). The pandemic has also created a favorable environment for local manufacturers and led to heightened demand for advanced CRRT devices, largely due to the increasing prevalence of fluid overload and the pursuit of improved patient outcomes. Additionally, advancements in pediatric CRRT products are expected to propel market expansion further. The U.S. remains the dominant player in the CRRT market, benefiting from a high prevalence of AKI and a robust healthcare infrastructure characterized by numerous hospitals. This is compounded by the rising hospital admissions linked to AKI and the growing incidence of end-stage renal disease, providing a strong foundation for market growth in the region. As these trends unfold, the U.S. CRRT market is projected to sustain a steady compound annual growth rate (CAGR) in the forthcoming forecast period, highlighting a promising outlook for stakeholders in the healthcare sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the global continuous renal replacement therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

global continuous renal replacement therapy Market Segmental Analysis

Global Continuous Renal Replacement Therapy Market is segmented on the product, modality, age group, end user, and region. By product, market is segmented into dialysate & replacement fluids, disposables, and CRRT Systems. By modality, market is segmented into continuous venovenous hemofiltration, continuous venovenous hemodiafiltration, continuous venovenous hemodialysis, and slow continuous ultrafiltration. By age group, market is segmented into adults, and pediatrics & neonates. By end user, market is segmented into hospitals, ambulatory care, home care, and other end users. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the global continuous renal replacement therapy Market

The increasing prevalence of acute kidney injury (AKI) serves as a significant market driver for the global continuous renal replacement therapy (CRRT) market. With a rise in cases particularly among critically ill patients and individuals with pre-existing health conditions, the demand for effective renal replacement therapies is surging. AKI is frequently encountered in intensive care units, where CRRT is the preferred method due to its ability to provide continuous and controlled dialysis in unstable patients. This uptick in AKI cases not only elevates the need for CRRT devices and consumables but also enhances market growth opportunities for manufacturers and healthcare providers alike, as timely intervention is crucial for improving patient outcomes.

Restraints in the global continuous renal replacement therapy Market

The high cost of Continuous Renal Replacement Therapy (CRRT) represents a significant market restraint, particularly in regions with constrained healthcare resources and budgets. The expenses associated with CRRT treatment-including sophisticated equipment, consumables, and the need for specialized healthcare professionals-can create a financial barrier for hospitals and clinics, limiting their ability to implement these advanced therapies. Consequently, many healthcare facilities may be unable to adopt or sustain CRRT, reducing patient access to this critical treatment option. This financial strain not only hinders the adoption of CRRT but also stifles overall market growth by restricting outreach to underserved populations.

Market Trends of the global continuous renal replacement therapy Market

The global Continuous Renal Replacement Therapy (CRRT) market is witnessing significant growth driven by several interconnected trends. A surge in acute kidney injury (AKI) and chronic kidney disease (CKD) cases, particularly among the aging population and those with comorbid conditions like diabetes and hypertension, is propelling the demand for CRRT devices and consumables. Additionally, technological innovations are enhancing the efficiency and user experience of CRRT machines, with features like electronic medical record connectivity and remote monitoring improving patient outcomes. Furthermore, the trend towards home-based CRRT is gaining traction, emphasizing patient convenience and potentially lowering healthcare costs. Together, these trends highlight a robust market evolution towards advanced, patient-centric renal care solutions.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Patent Analysis
• Trade Analysis
• Technology Analysis
• Value Chain Analysis
• Customer & Buying Criteria Analysis

Continuous Renal Replacement Therapy Market, By Product

• Market Overview
• Dialysate & Replacement Fluids
• Disposables
  • Hemofilters
  • Bloodline Sets & Tubes
  • Other Disposables
• CRRT Systems

Continuous Renal Replacement Therapy Market, By Modality

• Market Overview
• Continuous Venovenous Hemofiltration
• Continuous Venovenous Hemodiafiltration
• Continuous Venovenous Hemodialysis
• Slow Continuous Ultrafiltration

Continuous Renal Replacement Therapy Market, By Age Group

• Market Overview
• Adults
• Pediatrics & Neonates

Continuous Renal Replacement Therapy Market, By End User

• Market Overview
• Hospitals
• Ambulatory Care
• Home Care
• Other End Users

Continuous Renal Replacement Therapy Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Baxter International, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Medical Care AG & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikkiso Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Toray Medical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Infomed SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medica SPA (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medites Pharma Spol. S.R.O. (Czech Republic)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medical Components, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SWS Hemodialysis Care Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ningbo Tianyi Medical Devices Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anjue Medical Equipment Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kimal (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangxi Sanxin Medtech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allmed Medical Products Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dialco Medical Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Browndove Healthcare Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Steris PLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kuraray Medical PLC (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Livanova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diaverum Deutschland GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sembcorp Industries (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments